Highlights from the 2023 International Meeting on the Molecular Biology of Hepatitis B virus

Hbv, Lena Allweiss, Chari Cohen, Joao Dias, Valeria Fumagalli, Haitao Guo, James M. Harris, Jianming Hu, Matteo Iannacone, Masanori Isogawa, Wen Juei Jeng, Kyun Hwan Kim, Anna Kramvis, Wenhui Li, Julie Lucifora, Masamichi Muramatsu, Christine Neuveut, Alexander Ploss, Teresa Pollicino, Ulrike ProtzerAnthony Tan, Yasuhito Tanaka, Thomas Tu, Senko Tsukuda, Robert Thimme, Stephan Urban, Koichi Watashi, Zhenghong Yuan, Shiou Hwei Yeh, Jane A. McKeating, Peter A. Revill

Research output: Contribution to journalReview articlepeer-review

Abstract

Since its discovery in 1965, our understanding of the hepatitis B virus (HBV) replication cycle and host immune responses has increased markedly. In contrast, our knowledge of the molecular biology of hepatitis delta virus (HDV), which is associated with more severe liver disease, is less well understood. Despite the progress made, critical gaps remain in our knowledge of HBV and HDV replication and the mechanisms underlying viral persistence and evasion of host immunity. The International HBV Meeting is the leading annual scientific meeting for presenting the latest advances in HBV and HDV molecular virology, immunology, and epidemiology. In 2023, the annual scientific meeting was held in Kobe, Japan and this review summarises some of the advances presented at the Meeting and lists gaps in our knowledge that may facilitate the development of new therapies.

Original languageEnglish (US)
JournalJournal of General Virology
Volume105
Issue number5
DOIs
StatePublished - May 1 2024

All Science Journal Classification (ASJC) codes

  • Virology

Cite this